Cormorant Asset Management, LP Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$4.2B
Holdings
104
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (104 positions)
| Stock | Value |
|---|---|
—TURNING POINT THERAPEUTICS I | $291.5M |
AVIRATEA PHARMACEUTICALS INC | $259.8M |
NDQINVESCO QQQ TR | $235.3M |
XBISPDR SER TR | $211.2M |
SPYSPDR S&P 500 ETF TR | $186.9M |
BBIOBRIDGEBIO PHARMA INC | $161.1M |
—FORMA THERAPEUTICS HLDGS INC | $155.7M |
OLMAOLEMA PHARMACEUTICALS INC | $148.2M |
APLSAPELLIS PHARMACEUTICALS INC | $106.7M |
RVMDREVOLUTION MEDICINES INC | $98.8M |
IWMISHARES TR | $98.0M |
STOKSTOKE THERAPEUTICS INC | $89.0M |
YMABUSDY-MABS THERAPEUTICS INC | $82.3M |
CCCCC4 THERAPEUTICS INC | $80.0M |
ALXOALX ONCOLOGY HLDGS INC | $76.0M |
BEAMBEAM THERAPEUTICS INC | $75.5M |
BCABBIOATLA INC | $75.4M |
RCKTROCKET PHARMACEUTICALS INC | $75.1M |
CCXIEURCHEMOCENTRYX INC | $74.3M |
IMVTIMMUNOVANT INC | $72.2M |
OMEROMEROS CORP | $71.4M |
MRTXEURMIRATI THERAPEUTICS INC | $71.4M |
TARSTARSUS PHARMACEUTICALS INC | $70.0M |
RNAAVIDITY BIOSCIENCES INC | $62.9M |
RETAEURREATA PHARMACEUTICALS INC | $61.8M |
PRAXPRAXIS PRECISION MEDICINES I | $57.7M |
—ZYMEWORKS INC | $56.7M |
XLRNACCELERON PHARMA INC | $54.4M |
1K0IGM BIOSCIENCES INC | $53.0M |
—VIELA BIO INC | $51.4M |
—MYOVANT SCIENCES LTD | $47.0M |
—BIOHAVEN PHARMACTL HLDG CO L | $36.4M |
AXNX*AXONICS MODULATION TECHNOLOG | $34.6M |
ALGSALIGOS THERAPEUTICS INC | $34.5M |
TWSTTWIST BIOSCIENCE CORP | $31.8M |
SRNESORRENTO THERAPEUTICS INC | $30.7M |
CRSPCRISPR THERAPEUTICS AG | $30.6M |
MASS908 DEVICES INC | $29.5M |
GLTOUSDGALECTO INC | $26.5M |
ZLABZAI LAB LTD | $25.6M |
2L9BLUEPRINT MEDICINES CORP | $25.2M |
CABACABALETTA BIO INC | $23.8M |
SPRYSILVERBACK THERAPEUTICS INC | $23.2M |
BNTXBIONTECH SE | $22.4M |
AGENEURAGENUS INC | $22.3M |
—NOVUS THERAPEUTICS INC | $21.4M |
KURAKURA ONCOLOGY INC | $21.2M |
FHTXFOGHORN THERAPEUTICS INC | $20.3M |
AKROAKERO THERAPEUTICS INC | $19.2M |
INSPINSPIRE MED SYS INC | $18.8M |
BDQMALBIREO PHARMA INC | $18.8M |
OTICEUROTONOMY INC | $16.8M |
ASNDASCENDIS PHARMA A/S | $16.7M |
NTLAINTELLIA THERAPEUTICS INC | $16.3M |
AXSMAXSOME THERAPEUTICS INC | $16.3M |
—TCR2 THERAPEUTICS INC | $15.5M |
ANABANAPTYSBIO INC | $14.0M |
PLRXPLIANT THERAPEUTICS INC | $13.9M |
SRPTSAREPTA THERAPEUTICS INC | $11.9M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $11.4M |
RPTXREPARE THERAPEUTICS INC | $10.3M |
—HEALTH SCIENCES ACQ CORP 2 | $10.2M |
5E7ITEOS THERAPEUTICS INC | $10.1M |
IM8NINSMED INC | $10.0M |
—AKOUOS INC | $9.9M |
TBPHTHERAVANCE BIOPHARMA INC | $9.8M |
—HARPOON THERAPEUTICS INC | $9.5M |
—BCTG ACQUISITION CORP | $9.2M |
SWTXSPRINGWORKS THERAPEUTICS INC | $9.1M |
QUREUNIQURE NV | $9.0M |
ARGXARGENX SE | $8.8M |
TARAPROTARA THERAPEUTICS INC | $8.5M |
FDMT4D MOLECULAR THERAPEUTICS IN | $8.3M |
GOSSGOSSAMER BIO INC | $8.2M |
—QUOTIENT LTD | $7.8M |
ALLKGUSDALLAKOS INC | $7.0M |
—THERAPEUTICS ACQUISITION COR | $7.0M |
MORFMORPHIC HLDG INC | $6.7M |
MRUSMERUS N V | $6.1M |
—GENETRON HLDGS LTD | $5.6M |
—BCLS ACQUISITION CORP | $5.5M |
—FS DEV CORP | $5.5M |
—5 01 ACQUISITION CORP | $5.1M |
CLDNEUREIGER BIOPHARMACEUTICALS INC | $4.9M |
—VESPER HEALTHCARE ACQSTN COR | $4.8M |
REPLREPLIMUNE GROUP INC | $4.8M |
MLTXHELIX ACQUISITION CORP | $4.7M |
BCELATRECA INC | $4.7M |
AUTLAUTOLUS THERAPEUTICS PLC | $3.8M |
—KADMON HLDGS INC | $3.5M |
—AVROBIO INC | $3.4M |
—PANACEA ACQUISITION CORP | $3.2M |
1T7TRICIDA INC | $3.0M |
DTILPRECISION BIOSCIENCES INC | $2.9M |
CRDFCARDIFF ONCOLOGY INC | $2.7M |
ARNAEURARENA PHARMACEUTICALS INC | $1.5M |
—MIRAGEN THERAPEUTICS INC | $1.5M |
ORTXUSDORCHARD THERAPEUTICS PLC | $1.1M |
FATEFATE THERAPEUTICS INC | $909K |
—CEREVEL THERAPEUTICS HLDNG I | $753K |
Page 1 of 2Next